Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 7, 1996, Pages 1715-1716

  Gillum, J Gregory ^a   Israel, Debra S ^a   Scott, R Brad ^a,c   Climo, Michael W ^a   Polk, Ron E ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Heritage Information Systems ^*  (United States)

^c Heritage Information Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; THEOPHYLLINE;

ADULT; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIGESTIVE SYSTEM ULCER; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; HUMAN EXPERIMENT; MALE; MANIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER;

EID: 0029993257     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.7.1715     Document Type: Article

References (18)

1. Akaike, H. 1976. An information criterion (AIC). Math. Sci. 14:5-9.
2. Fuhr, U., E.-M. Anders, G. Mahr, F. Sörgel, and A. H. Staib. 1992. Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro. Antimicrob. Agents Chemother. 36:942-948.
3. Gascon, M. P., and P. Dayer. 1991. Comparative effects of macrolide antibiotics on liver microoxygenases. Clin. Pharmacol. Ther. 49:158.
4. Glantz, S. A. 1992. Primer of biostatistics, 3rd ed., p. 278-319. McGraw-Hill Inc., New York.
5. Gu, L., F. J. Gonzales, W. Kalow, and B. K. Tang. 1992. Biotransformation of caffeine, paraxanthine, theobromine, and theophylline by c-DNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 2:73-77.
6. Ha, H. R., J. Chen, A. U. Freiburghaus, and F. Follath. 1995. Metabolism of theophylline by cDNA-expressed human cytochrome P-450. Br. J. Clin. Pharmacol. 39:321-326.
7. Hendeles, L., J. Jenkins, and R. Temple. 1995. Revised FDA labeling guidelines for theophylline oral dosage forms. Pharmacotherapy 15:409-427.
8. MicroMath Scientific Software. 1988. RSTRIP-polyexponential curve fitting/least squares parameter estimation. Micromath Inc., Salt Lake City, Utah.
9. Nikki, Y., M. Nakajima, K. Tsukiyama, and R. Soejima. 1988. Effect of TE-031 (A-56268), a new oral macrolide antibiotic, on serum theophylline concentration. Chemotherapy (Tokyo) 36(Suppl. 3):51-52.
10. Parent, M., and M. LeBel. 1991. Meta-analysis of quinolone-theophylline interactions. DICP - Ann. Pharmacother. 25:191-194.
11. Periti, P., T. Mazzei, E. Mini, and A. Novelli. 1992. Pharmacokinetic drug interactions of macrolides. Clin. Pharmacokinet. 23:106-131.
12. Rieder, M. J., and M. Spino. 1988. The theophylline-erythromycin interaction. J. Asthma 25:195-204.
13. Rockwood, R. P., and L. S. Embardo. 1993. Theophylline, ciprofloxacin, and erythromycin: a potentially harmful regimen. Ann. Pharmacother. 27:651-652. (Letter.)
14. Ruff, F., S.-Y. Chu, L. T. Senello, and R. C. Sonders. 1990. Effect of multiple doses of clarithromycin (C) on the pharmacokinetics (Pks) of theophylline (T), abstr. 761, p. 213. In Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
15. Sarkar, M., C. Hunt, P. S. Guzelian, and T. Karnes. 1992. Characterization of human liver cytochromes P-450 involved in theophylline metabolism. Drug Metab. Dispos. 20:31-37.
16. Siepman, N. 1993. Influence of clarithromycin on theophylline levels in patients with bronchial infections. Presented at the 18th International Congress of Chemotherapy, June 27 to July 2, 1993, Stockholm, Sweden.
17. Tröger, U., and F. P. Meyer. 1995. Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Clin. Pharmacokinet. 28:287-314.
18. Watson, P. B. 1992. Drug metabolism by cytochromes P450 in the liver and small bowel. Gastroenterol. Clin. North Am. 21:511-526.